Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 4:39 pm Sale |
2020-12-31 | 13G | PREVAIL THERAPEUTICS INC PRVL |
RA Capital Management, L.P. | 0 0.000% |
-3,363,605 (Position Closed) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | PREVAIL THERAPEUTICS INC PRVL |
Citadel Advisors LLC | 2,421,024 7.100% |
7,143 (+0.30%) |
Filing History |
| 2021-02-12 4:19 pm Sale |
2020-12-31 | 13G | PREVAIL THERAPEUTICS INC PRVL |
REGENXBIO Inc. RGNX |
0 0.000% |
-2,030,000 (Position Closed) |
Filing History |
| 2021-02-12 4:06 pm Sale |
2020-12-31 | 13G | PREVAIL THERAPEUTICS INC PRVL |
EcoR1 Capital LLC | 0 0.000% |
-2,248,306 (Position Closed) |
Filing History |
| 2021-01-29 4:15 pm Unchanged |
2021-01-20 | 13G | PREVAIL THERAPEUTICS INC PRVL |
JNE Partners LLP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-01-28 8:30 pm Sale |
2021-01-22 | 13D | PREVAIL THERAPEUTICS INC PRVL |
ORBIMED ADVISORS LLC | 0 0.000% |
-13,822,463 (Position Closed) |
Filing History |
| 2020-12-22 08:49 am Purchase |
2020-12-14 | 13D | PREVAIL THERAPEUTICS INC PRVL |
LILLY ELI & CO LLY |
18,858,511 53.300% |
18,858,511 (New Position) |
Filing History |
| 2020-10-08 4:02 pm Purchase |
2020-09-28 | 13G | PREVAIL THERAPEUTICS INC PRVL |
Citadel Advisors LLC | 2,413,881 7.100% |
2,413,881 (New Position) |
Filing History |